Oral etoposide for recurrent/progressive sarcomas of childhood.
D000284:Administration, Oral; D000293:Adolescent; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage* / Q000633:toxicity; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005047:Etoposide / Q000008:administration & dosage* / Q000633:toxicity; D005260:Female; D006801:Humans; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D010166:Palliative Care; D012008:Recurrence; D012074:Remission Induction; D012509:Sarcoma / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D015996:Survival Rate; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide